跳至主要内容
临床试验/EUCTR2021-004021-71-NL
EUCTR2021-004021-71-NL进行中(未招募)1 期

COrticosteroids for COVID-19 induced loss of Smell – COCOS trial - COCOS trail

niversity Medical Center Utrecht0 个研究点目标入组 116 人开始时间: 2021年10月12日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
116

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Recent COVID-19 infection (<3 months), confirmed with a positive test (PCR of antigen by GGD)
  • Persistent loss of smell after one month, objectified by TDI < 30.5 on Sniffin’ Stick test
  • Age 18 years or older, capable of giving informed consent
  • Good understanding of the dutch language
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 26

排除标准

  • Pre-existing olfactory disorders
  • Chronic rhinitis or rhinosinusitis (with or without nasal polyps)
  • Corticosteroids (nasal, oral or intravenously) since positive test
  • Contra-indications of steroid use (Insulin dependent diabetes mellitus, Ulcus pepticum)

研究者

相似试验